← Open Payments lookup

RAMON RAMIREZ: Open Payments

NPI 1760008304 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,804 in 175 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $1,795 · 2025 $3,804

Food & beverage: $3,729Education: $75
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP32$1,080
GlaxoSmithKline, LLC.28$460
GENZYME CORPORATION16$294
Boehringer Ingelheim Pharmaceuticals, Inc.14$257
Regeneron Healthcare Solutions, Inc.17$233
Mallinckrodt Hospital Products Inc.6$182
Viatris Specialty LLC11$171
Pulmonx Corporation2$171
Takeda Pharmaceuticals U.S.A., Inc.8$154
United Therapeutics Corporation5$145

Products named: DUPIXENT, FASENRA, TRELEGY ELLIPTA, NUCALA, OFEV, AIRSUPRA, ACTHAR, YUPELRI.

Industry payments across OK — which companies pay providers there.